Literature DB >> 12482548

Scavenger receptor BI (SR-BI) mediates a higher selective cholesteryl ester uptake from LpA-I compared with LpA-I:A-II lipoprotein particles.

Franz Rinninger1, May Brundert, Ralph-M Budzinski, Jean-Charles Fruchart, Heiner Greten, Graciela R Castro.   

Abstract

Scavenger receptor class B, type I (SR-BI) mediates the selective uptake of high-density lipoprotein- (HDL-) associated cholesteryl esters (CE), i.e. lipid uptake independent from HDL holo-particle internalisation. This pathway contributes to the HDL-mediated CE delivery to the liver. From human plasma HDL, two major lipoprotein subfractions can be isolated: one contains apolipoprotein (apo) A-I and apo A-II (LpA-I:A-II) as dominant protein components, whereas in the other population apo A-II is absent (LpA-I). In this investigation the role of SR-BI in selective CE uptake from HDL, LpA-I and LpA-I:A-II was explored. HDL(3) (d=1.125-1.21 g/ml), LpA-I and LpA-I:A-II were isolated from human plasma and radiolabeled in the protein (125I) as well as in the CE moiety ([3H]). Baby hamster kidney (BHK) cells were stably transfected with the full-length human SR-BI cDNA and these cells demonstrate SR-BI expression in immunoblots. In contrast, no SR-BI protein was detectable in control BHK cells (vector). To investigate lipoprotein uptake, cells incubated (37 degrees C, 4 h) in medium containing radiolabeled HDL(3), LpA-I or LpA-I:A-II and finally cellular tracer content was determined. For both types of BHK cells, the rate of apparent lipoprotein particle uptake according to the lipid tracer ([3H]) was in substantial excess over that due to the protein tracer (125I) demonstrating selective CE uptake ([3H]-(125)I) from HDL(3), LpA-I and LpA-I:A-II. SR-BI expression increased cellular selective CE uptake from labeled HDL(3) up to 24-fold. In BHK cells without SR-BI expression, selective CE uptake was higher from LpA-I compared with LpA-I:A-II. Analogously, in BHK cells with SR-BI expression, the rate of selective CE uptake was higher from LpA-I compared with LpA-I:A-II. In summary, SR-BI significantly increases selective CE uptake from HDL(3), LpA-I and LpA-I:A-II. Concerning HDL subfractions, the rate of SR-BI-mediated selective CE uptake is greater from LpA-I compared with LpA-I:A-II and this result suggests that SR-BI preferentially facilitates the CE transfer from LpA-I lipoprotein particles to cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12482548     DOI: 10.1016/s0021-9150(02)00311-8

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  6 in total

1.  Combining beta-adrenergic and peroxisome proliferator-activated receptor gamma stimulation improves lipoprotein composition in healthy moderately obese subjects.

Authors:  Thomas A Hughes; Frankie Stentz; Thomas Gettys; Steven R Smith
Journal:  Metabolism       Date:  2006-01       Impact factor: 8.694

Review 2.  The metabolism and anti-atherogenic properties of HDL.

Authors:  Kerry-Anne Rye; Christina A Bursill; Gilles Lambert; Fatiha Tabet; Philip J Barter
Journal:  J Lipid Res       Date:  2008-11-24       Impact factor: 5.922

3.  Kinetic stabilization and fusion of apolipoprotein A-2:DMPC disks: comparison with apoA-1 and apoC-1.

Authors:  Shobini Jayaraman; Donald L Gantz; Olga Gursky
Journal:  Biophys J       Date:  2005-01-28       Impact factor: 4.033

4.  Role of apolipoprotein A-II in the structure and remodeling of human high-density lipoprotein (HDL): protein conformational ensemble on HDL.

Authors:  Xuan Gao; Shujun Yuan; Shobini Jayaraman; Olga Gursky
Journal:  Biochemistry       Date:  2012-06-01       Impact factor: 3.162

5.  High-density lipoprotein as a potential carrier for delivery of a lipophilic antitumoral drug into hepatoma cells.

Authors:  Bin Lou; Xue-Ling Liao; Man-Ping Wu; Pei-Fang Cheng; Chun-Yan Yin; Zheng Fei
Journal:  World J Gastroenterol       Date:  2005-02-21       Impact factor: 5.742

6.  eNOS activation by HDL is impaired in genetic CETP deficiency.

Authors:  Monica Gomaraschi; Alice Ossoli; Silvia Pozzi; Peter Nilsson; Angelo B Cefalù; Maurizio Averna; Jan Albert Kuivenhoven; G Kees Hovingh; Fabrizio Veglia; Guido Franceschini; Laura Calabresi
Journal:  PLoS One       Date:  2014-05-15       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.